Animal Models of Parkinson's Disease: Vertebrate Genetics

  1. Ted M. Dawson1,3,4,5
  1. 1NeuroRegeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
  2. 2Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
  3. 3Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
  4. 4Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
  5. 5Adrienne Helis Malvin Medical Research Foundation, New Orleans, Louisiana 70130-2685
  1. Correspondence: tdawson{at}jhmi.edu

Abstract

Parkinson's disease (PD) is a complex genetic disorder that is associated with environmental risk factors and aging. Vertebrate genetic models, especially mice, have aided the study of autosomal-dominant and autosomal-recessive PD. Mice are capable of showing a broad range of phenotypes and, coupled with their conserved genetic and anatomical structures, provide unparalleled molecular and pathological tools to model human disease. These models used in combination with aging and PD-associated toxins have expanded our understanding of PD pathogenesis. Attempts to refine PD animal models using conditional approaches have yielded in vivo nigrostriatal degeneration that is instructive in ordering pathogenic signaling and in developing therapeutic strategies to cure or halt the disease. Here, we provide an overview of the generation and characterization of transgenic and knockout mice used to study PD followed by a review of the molecular insights that have been gleaned from current PD mouse models. Finally, potential approaches to refine and improve current models are discussed.

Also in this Collection

    | Table of Contents

    Richard Sever interviews Joan Brugge